 |
 |
 |
 |
 |
 |
Takeda Pharmaceutical Company Limited (Takeda) has joined the Structural Genomics Consortium (SGC) to fund collective drug research aimed at bringing new, more effective medicines to market faster.
SGC Press Releases
Wednesday 28th September 2011
The international Structural Genomics Consortium (SGC) today announced $48.9 million in new funding has been attained
Wednesday 28th September 2011
"Sleeping sickness", also known as human African trypanosomiasis, is responsible for approximately 30,000 deaths each year and 70 million people are at risk of infection, as estimated by the World Health Organization
Wednesday 28th September 2011
Functional and localization experiments in mammalian cells have demonstrated that Mps1 is essential for the fidelity of the cell cycle and genomic stability.
Wednesday 28th September 2011
Apicomplexan parasites are a diverse group of protozoan parasites, several of which cause important human and animal diseases, such as malaria, cryptosporidiosis and toxoplasmosis
Wednesday 28th September 2011
SGC Oxford - Toxoplasmosis is a parasitic disease caused by the apicomplexan protozoa Toxoplasma gondii and can pose a significant threat to immunocompromised individuals, e.g. those undergoing organ transplantation or chemotherapy and HIV/AIDS patients, who cannot fight back the infection and are thus dependent on drugs to control the infection.
Wednesday 28th September 2011
The Structural Genomics Consortium (SGC) and Pfizer today announced that Pfizer will join the SGC-led public-private collaboration to generate small molecule inhibitors – "chemical probes" – for proteins involved in epigenetic signaling. Pfizer and GlaxoSmithKline (GSK) are now members of this collaboration, launched in late 2008 with the aim to provide the community with high quality research reagents, free from restriction on use.
Wednesday 28th September 2011
The SGC has been awarded more than 0.5 M Euro as part of a joint EU FP7 -Health grant: 'Protein Binders for Characterisation of Human Proteome Function: Generation, Validation, Application "Affinomics", which encompasses 15 participant labs in eight different European countries for 5 years.
Wednesday 28th September 2011
Two influential journals are now accepting and publishing articles that are enhanced using a unique platform known as iSee (interactive Structurally enhanced experience), developed in a collaboration between the SGC's Dr. Brian Marsden and Dr. Wen Hwa Lee, with Prof. Ruben Abagyan and his team from MolSoft L.L.C. This platform, featuring animations that 'fly' the reader through the structural representation to the specific molecular feature being described, has already been successfully employed in a pioneering PLoS ONE Collection highlighting a number of protein structures from the SGC.
Wednesday 28th September 2011
The Structural Genomics Consortium (SGC), an international public-private partnership that aims to determine three dimensional structures of medically important proteins, announced today the release into the public domain of its 1000th high resolution protein structure.
Pages
